title: Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation.
abstract: In vitro proliferation of peripheral blood mononuclear cells was used to measure virus-specific cell-mediated immunity (vCMI) following neonatal woodchuck hepatitis virus (WHV) infection. Fifteen neonates were inoculated with the W8 strain of WHV. In 11, infection was resolved, and 4 became chronic carriers. Nineteen neonates were inoculated with the W7 strain and all became chronic carriers. Seven age-matched uninfected woodchucks served as controls. Virologic and vCMI profiles among the W8 and W7 infections were compared and related to the outcome of infection. Resolving woodchucks had robust, acute-phase vCMI to WHV antigens (core, surface, and x) and to several nonoverlapping core peptides. The acute-phase vCMI was associated temporally with the clearance of viral DNA and of surface antigen from serum at 14 to 22 weeks postinfection. In contrast, in approximately half of the W8 and W7 infections that progressed to chronicity, no significant acute-phase vCMI was detected. In the remaining carriers, acute-phase vCMI was observed, but it was less frequent and incomplete compared to that of resolved woodchucks. Serum viral load developed less rapidly in those carriers that had evidence of acute-phase vCMI, but it was still increased compared to that of resolving woodchucks. Thus, vigorous and multispecific acute-phase vCMI was associated with resolution of neonatal WHV infection. Absent or incomplete acute-phase vCMI was associated with the progression to chronic infection. By analogy, these results suggest that the onset of chronic hepatitis B virus (HBV) infection in humans may be associated with deficiencies in the primary T-cell response to acute HBV infection.
authors.affiliation: Gastrointestinal Unit, Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA. sm119@cornell.edu
authors.forename: Stephan
authors.initials: S
authors.lastname: Menne
authors.forename: Carol A
authors.initials: CA
authors.lastname: Roneker
authors.forename: Michael
authors.initials: M
authors.lastname: Roggendorf
authors.forename: John L
authors.initials: JL
authors.lastname: Gerin
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Cote
authors.forename: Bud C
authors.initials: BC
authors.lastname: Tennant
mesh_terms: D000208:Acute Disease; D000818:Animals; D000831:Animals, Newborn; D004279:DNA, Viral / Q000097:blood; D018450:Disease Progression; D005260:Female; D018963:Hepatitis Antigens / Q000276:immunology*; D006509:Hepatitis B / Q000276:immunology* / Q000503:physiopathology* / Q000821:virology; D017919:Hepatitis B Virus, Woodchuck / Q000276:immunology*; D019694:Hepatitis B, Chronic / Q000276:immunology / Q000503:physiopathology / Q000821:virology; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D008297:Male; D008392:Marmota; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D004279:DNA, Viral; D018963:Hepatitis Antigens